Integrated transcriptome analysis and machine learning to construct a homeostatic model of acetylation for bladder cancer and validate the key gene CES1
Jingliang Cao, Jiaqing Yang, Weifeng Shang, Hengxing Tan, Qiang Zhou, Bo Jia, Ju Guo · 2026
Read Integrated transcriptome analysis and machine learning to construct a homeostatic model of acetylation for bladder cancer and validate the key gene CES1 by Jingliang Cao, Jiaqing Yang, Weifeng Shang, Hengxing Tan, Qiang Zhou, Bo Jia, Ju Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13561738.txt.
Description
Cao and colleagues build a survival model for bladder cancer from genes tied to protein acetylation, a chemical tagging process that helps cells keep internal balance, in 2026 oncology research. Combining gene activity data with machine learning, they distilled the signal into a five-gene model. The model split patients into risk groups and was tested as a stand-alone predictor of overall survival alongside standard clinical factors.
High-risk patients showed much poorer survival, distinct immune cell mixtures inside their tumors, and different sensitivity to drugs. One gene, CES1, stood out: it was highly active in bladder cancer and tracked with worse outlook. Silencing CES1 in lab cells markedly suppressed their growth, invasion, and migration, and lowered levels of coenzyme A, a molecule central to acetylation chemistry. Cao suggests CES1 as both a prognostic marker and a possible drug target, pending deeper work.
Catalog record
| CREATOR | Jingliang Cao, Jiaqing Yang, Weifeng Shang, Hengxing Tan, Qiang Zhou, Bo Jia, Ju Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |